EKG — CardioComm Solutions Share Price
0.000.00%
Last trade - 00:00- CA$2.90m
- CA$3.21m
- CA$0.53m
- 43
- 23
- 31
- 22
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.68 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -58.13% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 0.83 | 0.68 | 1 | 0.88 | 0.53 | n/a | n/a | -9.65% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CardioComm Solutions, Inc. develops advanced software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company’s proprietary device connectivity and ECG management technologies are used in medical, consumer, clinical research and telemedicine solutions for recording, transmission, viewing, analyzing, reporting and storage of ECGs. The Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud-based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians. It also holds Class II medical device clearances for the manufacture, marketing, and sales of personal ECG monitors direct to consumers. The products are marketed under the HeartCheck brand. It developed compatibility of the HeartCheck device to its GEMS and GlobalCardio based software to enable use of the device for remote ECG/arrhythmia monitoring services.
Directors
- Robert Caines NEC
- Etienne Grima CEO
- Josee Bertrand CFO
- Steven Benyo IND
- John Foote IND
- Simi Grosman IND
- David Newman IND
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- October 26th, 1989
- Public Since
- July 6th, 1995
- No. of Employees
- 16
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 193,074,006
- Address
- 18 Wynford Drive, Suite 305, NORTH YORK, M3C 3S2
- Web
- https://www.cardiocommsolutions.com/
- Phone
- +1 4169779425
- Auditors
- Buckley Dodds LLP
Upcoming Events for EKG
Q3 2025 CardioComm Solutions Inc Earnings Release
CardioComm Solutions Inc Annual Shareholders Meeting
Similar to EKG
Aurora Spine
TSX Venture Exchange
Cheelcare
TSX Venture Exchange
Conavi Medical
TSX Venture Exchange
Covalon Technologies
TSX Venture Exchange
EvokAI Creative Labs
TSX Venture Exchange
FAQ
What is the CardioComm Solutions share price?
As of Today at 10:48 UTC, shares in CardioComm Solutions are trading at CA$0.02. This share price information is delayed by 15 minutes.
How has the CardioComm Solutions share price performed this year?
Shares in CardioComm Solutions last closed at CA$0.02 and the price had moved by +50% over the past 365 days. In terms of relative price strength the CardioComm Solutions share price has outperformed the Toronto Stock Exchange 300 Composite Index by +25.04% over the past year.
What are the analyst and broker recommendations for CardioComm Solutions?
There is no consensus recommendation for this security.
Find out moreWhat is the CardioComm Solutions dividend yield?
CardioComm Solutions does not currently pay a dividend.
Does CardioComm Solutions pay a dividend?
CardioComm Solutions does not currently pay a dividend.
When does CardioComm Solutions next pay dividends?
CardioComm Solutions does not currently pay a dividend.
How do I buy CardioComm Solutions shares?
To buy shares in CardioComm Solutions you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of CardioComm Solutions?
As of the previous close price of CA$0.02, shares in CardioComm Solutions had a market capitalisation of CA$2.90m.
Where are CardioComm Solutions shares listed?
Here are the trading details for CardioComm Solutions:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: EKG
What kind of share is CardioComm Solutions?
Based on an overall assessment of its quality, value and momentum CardioComm Solutions is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a CardioComm Solutions share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the CardioComm Solutions share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CardioComm Solutions. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -7.4%.
As of the last closing price of CA$0.02, shares in CardioComm Solutions were trading +23.97% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the CardioComm Solutions PE Ratio?
The CardioComm Solutions PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of CardioComm Solutions?
CardioComm Solutions' management team is headed by:
- Robert Caines - NEC
- Etienne Grima - CEO
- Josee Bertrand - CFO
- Steven Benyo - IND
- John Foote - IND
- Simi Grosman - IND
- David Newman - IND